Also from this source

You just read:

Sixty Percent of Surveyed Type 2 Diabetes Patients in the U.S. Who Use Insulin Indicate They Would Request a Switch to a Less Expensive Biosimilar Insulin if Such an Agent Became Available

News provided by

Decision Resources

Dec 23, 2010, 08:00 EST